212 related articles for article (PubMed ID: 9593593)
21. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
22. Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.
Rady JJ; Gorny JM; Fujimoto JM
Jpn J Pharmacol; 1998 Dec; 78(4):443-54. PubMed ID: 9920201
[TBL] [Abstract][Full Text] [Related]
23. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice.
Kest B; Beczkowska I; Franklin SO; Lee CE; Mogil JS; Inturrisi CE
Brain Res; 1998 Sep; 805(1-2):131-7. PubMed ID: 9733948
[TBL] [Abstract][Full Text] [Related]
24. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively.
Takemori AE; Portoghese PS
Eur J Pharmacol; 1993 Sep; 242(2):145-50. PubMed ID: 8253111
[TBL] [Abstract][Full Text] [Related]
25. Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Life Sci; 1994; 55(6):PL121-6. PubMed ID: 8035657
[TBL] [Abstract][Full Text] [Related]
26. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice.
Suzuki T; Yoshiike M; Mizoguchi H; Kamei J; Misawa M; Nagase H
Jpn J Pharmacol; 1994 Sep; 66(1):131-7. PubMed ID: 7861658
[TBL] [Abstract][Full Text] [Related]
27. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
28. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
Raffa RB; Martinez RP; Porreca F
Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
[TBL] [Abstract][Full Text] [Related]
29. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
30. Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography.
Mokhtari M; Tafani JA; Zajac JM
Neuropeptides; 1993 Sep; 25(3):183-91. PubMed ID: 8247256
[TBL] [Abstract][Full Text] [Related]
31. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
32. Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects.
Yu WZ; Ruegg H; Bodnar RJ
Pharmacol Biochem Behav; 1997 Mar; 56(3):353-61. PubMed ID: 9077569
[TBL] [Abstract][Full Text] [Related]
33. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
34. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
35. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
Lai J; Bilsky EJ; Rothman RB; Porreca F
Neuroreport; 1994 May; 5(9):1049-52. PubMed ID: 8080957
[TBL] [Abstract][Full Text] [Related]
36. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
37. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
Thorat SN; Hammond DL
J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
39. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
Crook TJ; Kitchen I; Hill RG
Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
[TBL] [Abstract][Full Text] [Related]
40. Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia/reperfusion.
Maslov LN; Oeltgen PR; Lishmanov YB; Brown SA; Barzakh EI; Krylatov AV; Pei JM
Acad Emerg Med; 2014 Jan; 21(1):31-9. PubMed ID: 24552522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
